ANI Pharmaceuticals announced U.S. Food and Drug Administration approval for the Abbreviated New Drug Application (ANDA) for Fludrocortisone Acetate Tablets USP, 0.1 mg.
ANI’s Fludrocortisone Acetate Tablets are the generic version of the Reference Listed Drug (RLD) Florinef®. The current annual U.S. market for Fludrocortisone Acetate Tablets, 0.1 mg is approximately $24.2M, according to IQVIA/IMS Health, a leading healthcare data and analytics provider.
www.anipharmaceuticals.com